Gene editing has undergone a revolutionary transformation with the advent of CRISPR-Cas9 technology, fundamentally altering the landscape of molecular biology and genectics. CRISPR-cas9, a bacterial immune system repurposed for precise genectic modification, allows for targeted alterations in the DNA of various organisms with unprecedented accuracy and efficiency. This technology has rapidly become a cornerstone in genectic research, therapeutic development, and agricultural biotechnology. Recent advancements in CRISPR-Cas9 have expanded its capabilities beyond simple gene knock-out and knock-in applications. Researchers are now utilizing CRISPR to perform complex edits, such as gene regulation and epigenectic modifications, providing deeper insights into gene function and regulation. The development of CRISPR activation (CRISPRi) and CRISPR activation (CRISPRa) has enabled the fine-tuning of gene expression, which is crucial for understanding gene networks and cellular processes. Additionally, the integration of CRISPR with other emerging technologies, such as single-cell sequencing both basic and applied research in therapeutic applications, CRISPR-Cas9 holds promise for treating genetic disorders, with early clinical trials showing potential in correcting mutations associated with diseases like sickle cell anemia and muscular dystrophy. Efforts are underway to enhance the delivery mechanism of CRISPR components to target cells more efficiently and reduce off-target effects, which remain a significant challenge. In agriculture CRISPR technology is being harnessed to create modified crops with improved traits such as diseases resistance and enhanced nutritional profiles. The ethical and regulatory implication of CRISPR-Cas9, particularly concerning germline editing and bioadversity. Overall, CRISPR-Cas9 technology represents a paradigm shift in genectic engineering, offering transformative potential across various fields. ongoing research and development are expected to refine its applications, unlock opportunities for scientific and medical advancements.
PDFShare this article
Journal of Clinical & Medical Genomics received 391 citations as per Google Scholar report
